å»è¬åå ¬è¡šãããæŽå¯
ããŠãšã³ç ã¯ãæå¹³çްèçã®æ©æåœ¢æ ã§ããããŸãã座ç¡ã®æå¹³çްèçãšããŠç¥ãããŠããŸãã äŸãã°ã2019幎2æã«ãªãŒãã³ã¢ã¯ã»ã¹ãã±ããã¢å»åŠãžã£ãŒãã«ãå ¬è¡šããèšäºã«ãããšãé䟵襲çãªããŠãšã³ç ã®çŽ3ã5%ã䟵襲çãªæå¹³æ§ã«ããããäœå šäœã«åºããç®èçã®ããæ·±å»ãªåœ¢æ ã«çºå±ããããšãæšå®ããŠããŸãã ããŠã³ç ã¯ãæãè¶³ãè¶³ãªã©ã®å€ªéœã«æãé²åºããŠããäœã®ããŸããŸãªéšåã«èµ€ã®ã¹ã«ãªããããç å€ã®ååšã«ãã£ãŠç¹åŸŽä»ããããŸãã ãããã®ç å€ãŸãã¯ã¹ã«ãªãããã¯éåžžãçã¿ãåºè¡ãªã©ã®çç¶ã«é¢é£ä»ããããŠããªãã ããŠã³ç ã«é¢äžããå±éºå åã®ããã€ãã¯ãã€ãªã³åæŸå°ç·ãå«ã¿ãŸã, ããããããŒããŠã€... ãã£ãšèŠã
èå¢ã¯ã乳幌å ã«å€§ããèµ·ãããŸããªç¶æ ã§ãã ãã®æ¡ä»¶ã§ã¯ãèæ±ãèèããèå¢ã«èŒžéããè管ããããã¯ãããŸãã ãã®ç æ°ã®çç¶ã¯ãåºç£åŸ2ã8é±éçšåºŠã§ãã èéäžæŽèã®çç¶ã«ã¯ãé»çžãæ·¡è²ã®ã¹ããŒã«ãé ããŸãã¯äœéå¢å ãæãå°¿ãããã³æ¡å€§ãããã¹ãã¬ã³ãå«ãŸããŠããŸãã èéäžç çãçããããšãæ©æã®æè¡ãæåããå¯èœæ§ãé«ããããè西ãã«ããšã³ããã¹ãããŒãšåŒã°ããæè¡ãè¡ãããå¿ èŠããããŸãã ã«ãµã€ã®åäœã倱æããå Žåã¯ãèç§»æ€ãå¿ èŠãªå ŽåããããŸããäžççãªèéæ²»çåžå Žã¯è©äŸ¡ããããšæšå®ããã US$ 910.7 çŸäž ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.7%... ãã£ãšèŠã
ãã³ãã³ãã³ç æ²»çè¬åžå Žãè¬å€ã¯ã©ã¹å¥ïŒå°èæ§ã¢ãã¢ãã³ãã©ã³ã¹ããŒã¿ãŒé»å®³å€ãã¢ãã¢ãã³æ¯æžè¬ãæããããè¬ãæãã€è¬ãæç²Ÿç¥ç è¬ãªã©ïŒãæäžçµè·¯å¥ïŒçµå£ããã³éçµå£ïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
ç±³åœãããã³ãšãŒãç³»ç¹éŒ»è¬åžå ŽãåŠæ¹ç®ã¿ã€ãå¥ïŒRxïŒåŠæ¹ç®ïŒããã³OTCïŒåºé ïŒïŒãé©å¿çå¥ïŒã¢ã¬ã«ã®ãŒæ§éŒ»çãéã¢ã¬ã«ã®ãŒæ§éŒ»çãæ ¢æ§éŒ»å¯éŒ»è ç/å¯éŒ»è çã錻詰ãŸãïŒé¢šéª/ã€ã³ãã«ãšã³ã¶ïŒãææçäºé²/æãŠã€ã«ã¹è¬ããã®ä»ïŒãæµéãã£ãã«å¥ïŒå°å£²ïŒ è¬å±ãç é¢è¬å±ããªã³ã©ã€ã³è¬å±ïŒ... ãã£ãšèŠã
ç æ°ä¿®é£Ÿã®æé¢ç¯è¬(DMARDs)ã¯äººã ã§äžè¬ã«äœ¿çšãããè¬å€ã®ã°ã«ãŒãã§ã é¢ç¯ãªãŠãããåãåãã ãããã®è¬ã®ããã€ãã¯ãèé«èçã也æ§é¢ç¯çãããã³å šèº«æ§è¿çŽ æçãªã©ã®ä»ã®æ¡ä»¶ã®æ²»çã«ã䜿çšãããŸãã ç 倿§æé¢ç¯è¬ã¯ãçã¿ãççãæžå°ãããé¢ç¯ã®æå·ãæå¶ããé¢ç¯ã®æ§é ãšæ©èœãç¶æããããã«åããŸããäžççãªç æ°ä¿®é£Ÿã®ærheumatic ã®è¬å€(DMARD)ã®åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$ 20,671.1 çŸäžå ãåãåãã 2022幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠3.5% äºå ±æéäž (2022-2030).å³1.Global çŸç ç·©åè¬(DMARD) å»è¬åã®çš®é¡ã... ãã£ãšèŠã
äžè¬çãªè «çåŠã®çæ®äžèœæ³šå°å€ã¯ããã©ã³ãçãšåãæå¹æåãæã€çç©åŠçããžãã¯ã§ãããç°ãªãè¬ã®éã¢ã¯ãã£ãã³ã³ãã³ãã®ã¿ã§ãã ãããã®äžè¬çãªè «çåŠã®çæ®äžèœã®æ³šå°åšã¯breastãåç«è ºãcolorectalãmelanomaãèºããã³bronchusãå«ãããŸããŸãªã¿ã€ãã®çã®åŠçœ®ã®ããã«äœ¿çšãããŸãã ãããã®æ³šå°åšã¯äœäŸ¡æ Œã§å©çšå¯èœã§ããããããã£ãŠããã©ã³ãã®è¬ãããåºã奜ãŸããŠããŸãã ããã«ããžã§ããªãã¯å»è¬åã®ç ç©¶éçºã¯ãããå°ãªãè³æ¬ãå¿ èŠãšããç«¶äºãå¢å ããåå ¥ãã äžè¬çãªè «çåŠã®çæ®äžèœã®æ³šå°å¯èœãªåžå Ž ãã©ã³ãã®æ³šå°çšæéãåãããšããã«ãAsia Pacifi... ãã£ãšèŠã
ç²èç(AS)ã¯ãäž»ã«èæ€ã«åœ±é¿ãåãŒããäœã®å€§ããªé¢ç¯ãå·ã€ããããšãã§ãããŸããªã¿ã€ãã®ççã§ãã èæ€é¢ç¯(èæ€)ã®ççãåŒãèµ·ãããé床ã®çã¿ãäžå¿«æãåŒãèµ·ãããŸãã æéãçµã€ã«ã€ããŠãèæ€ã®éªšã¯èæ€ã®éªšãçµåãããèæ€ãããæè»ã«ãªãããã«ããããšãã§ããŸãã èé«èçã®çç¶ã¯ãè °ã®çã¿ãšç¡¬ããå«ã¿ãèäžãäžããŸããã¹ãã¬ã³ãžã«ãçã®äžççãªåžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$ 4,864.3 çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠8.2% äºå ±æéäž (2021-2028).å³1.å»è¬åã®çš®é¡ã2021ã«ãã䟡å€ã®èгç¹ããã¹ãã¬ã³ãžã«çåžå Žã·ã§ã¢(%)... ãã£ãšèŠã
é»ç±ã¯ãäºé²æ¥çš®ãé²ãããšãã§ããææããèã®å¬å·ã«ãã£ãŠåŒãèµ·ããããæµè¡ã®åŸåã«ããç æ°ã§ãã é»ç±ã¯ãææããè(ãšã€ãã¹ãšãããŽã¬ã¹)ã«ãã£ãŠããã«åºãããèãããããŸãã¯ä»ã®é¢ç¯çãªã©ã®ãã¯ãã«ã«ãã£ãŠãã¢ã«ããŠã€ã«ã¹(ãŠã€ã«ã¹ãåºãã)ã«ãã£ãŠåŒãèµ·ããããŸãã ãããã®èã¯å®¶ã森ããžã£ã³ã°ã«ããŸãã¯äž¡æ¹ã®çæ¯å°ã§ç¹æ®ããŸãã é»ç±ã¯ãã°ããŒãã«ã«åºããå±éºæ§ã®ããé«è åšçŸæ£ã§ãããã°ããŒãã«ãã«ã¹ã»ãã¥ãªãã£ãžã®è åšãæç€ºããŸãã é»ç±ã®äžè¬çãªçç¶ã¯ãé çãç±ãåãæ°ãååãå«ãŸããŸãã éçäŸã§ã¯ãé»ç±ãå¿èãè èãèèãªã©ã®èåšã«åœ±é¿ãåãŒãå¯èœæ§ããããŸããäžççãªé»ç±åŠ... ãã£ãšèŠã
ç±³åœOTCç¹çŒè¬åžå Žã補åå¥ïŒSystaneãRefreshãBlinkãTheraTearsãRohtoããã®ä»ïŒãããã±ãŒãžã³ã°ã¿ã€ãå¥ïŒè€æ°åçšéããã«ãäœ¿ãæšãŠãã€ã¢ã«ïŒãé²è å€ã¹ããŒã¿ã¹å¥ïŒé²è å€å«æãé²è å€ããªãŒïŒãã¯ãŒã«ã¿ã€ãã¹ããŒã¿ã¹å¥ïŒã¯ãŒã«ããã³ã¯ãŒã«ïŒãæµéãã£ãã«å¥ïŒå°å£²è¬å±ããã³ãã©ãã°ã¹ãã¢ãé»ååååŒããã³ãªã³ã©ã€ã³ïŒ è¬å±ãã¹ãŒããŒããŒã±ããããã³ãã€ããŒããŒã±ãããçŒç§ã¯ãªããã¯ããã®ä»)... ãã£ãšèŠã
ãã¢ã€ãè «çã¯ãæªæ§ã§ã¯ãªãçµåçµç¹ã®æé·ã§ãã ãã¹ã¢ã€ãè «çã¯ãéåžžãè ãèãè ¹ã«çºéããŸãã ãã¢ã€ãè «çãç©æ¥µçãªç·ç¶è «çãšåŒã°ããŸãã è «çããã£ãããšæé·ããããã«æ²»çããå¿ èŠã¯ãããŸããã ãã®ä»ã¯æé·ã®æ¥éãªçããããå€ç§ãååŠçæ³ãæŸå°ç·çæ³ããŸãã¯ä»ã®è¬ç©ãšæ±ãããŸããäžçã®ãããè «çåžå Žã¯ãè©äŸ¡ããããšæšå®ããã US$ 2,494.1 çŸäžå ãåãåãã 2022幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.3%(çšæ) äºå ±æéäž (2022-2030).å³1.ã°ããŒãã«ãããè «çåžå Žã·ã§ã¢(%)ãè¬ç©ã®çš®é¡ã2022ã°ããŒãã«ãããè «çåžå Ž - ãã©ã€ã㌠ãã¢ã€ãè «çã®æ²»... ãã£ãšèŠã
äžççãªç£å» ãã«ã¹ã±ã¢åžå Žãè©äŸ¡ãããŸããUS$30,368.5 Mn2021幎(æå20幎)ã«äŸ¡å€ã®å°éãäºæž¬US$ 55,657.5 ã¡ãŒãã«ã«ãã£ãŠ2028幎ãåãåãã9.0%ã®CAGR éã®è·é¢2022幎ã2028幎ãåãåãã äžççãªç£å»å»çåžå Žã¯ãäžçäžã®èгè³ãé»é垯ççŸæ£ã®çœ¹æ£çã®å¢å ãæ¿åºãåç©çŠç¥åäŒã®æå©ãªåãçµã¿ã«ãã匷åãªæé·ãçµéšããŠããŸãã ãŸããåç©å»çã«çŠç¹ãåããããã³ãããã¯äžã«ãããã®æ¡çšã®å¢å ãæåŸ ãããåžå Žã®æé·ãä¿é²ããŸãã ããããåç©å»çãµãŒãã¹ã»ãœãªã¥ãŒã·ã§ã³ã®é«ã³ã¹ãããåœé åãå»è¬åã®å¯çšæ§ãªã©ã®èŠå ã¯ãåžå Žã®æé·ã劚ããããšãæåŸ ã... ãã£ãšèŠã
Intravenouså ç«ã°ãããªã³(IVIG)ã¯å ç«æåãé åããæ£è ã®æ²»çã§ãã IVIGã¯ãæ°å人ã®å¥åº·ãªå¯ä»è ã®è¡æŒ¿ããåŸãããå ç«ã°ãããªã³(æäœ)ã®ã³ã¬ã¯ã·ã§ã³ã§ããå ç«ã°ãããªã³ã¯ãææçãšã®æŠããæ¯æŽããããã«å¥åº·ãªäººã ã®å ç«ã·ã¹ãã ã«ãã£ãŠçæãããã¿ã³ãã¯è³ªã§ãã IVIGã¯è¡æŒ¿(è¡æ¶²è£œå)ããæŽŸçããŠããéãè¡æ¶²åªä»ææãåèšããå±éºæ§ã¯éåžžã«äœãããšã§ããIVIGã¯ãæ°æéãããéèå æ³šå ¥(è ã®éè)ãšããŠæäžãããå®äºããŸãã æ³šå ¥ã®é »åºŠã¯æ£è ã®å¿ èŠæ§ã«ãã£ãŠå€ãããŸããç±³åœéèå å ç«ã°ãããªã³åžå Ž - ã³ãããŠã€ã«ã¹ã®åœ±é¿(COVID-19)ãã³ãããã¯ã³ãããŠã€ã«... ãã£ãšèŠã
Vernal keratoconjunctivitis (VKC)ã¯ã¢ã¬ã«ã®ãŒæ§ã®ç®ã®ç æ°ã§ãã ããã¯ç¹ã«åäŸã«ç·æ§ã«ãäž»ã«åœ±é¿ãäžããå€å åã®Th2现èåªä»ãããæ¥åã®è¡šé¢ã®ççç¶æ ã§ãã æ¿ããããã¿ãçãããå ææçããã³æ¶ã¯æãäžè¬çãªçç¶ã§ãã æãäžè¬çãªå åã¯ãçµææ§é«è¡çãè¡šé¢æ§è§èçãããã³å·šå€§ãªè¿ç±ã§ãã ãã¹ã现èãTh2现èãã·ããããeosinophilsãä»çååãååŠãããã³ã·ãããã®éå°çºçŸã¯ãå èè§èçã®ç¹åŸŽã§ãã çµææµžå ¥ãå å©çŽãçµæç·ç¶å¢æ®ç å€ããã³çµèæ§é«è¡çã¯ãè ç®èçã®ç¹åŸŽã§ãã æ··åãpalpebralãããã³limbalã¯ãä¹³é ã®åå¿ã®äž»ãªè§£... ãã£ãšèŠã
Mesalazineã¯é©åºŠã«æŽ»åçãªæœ°çæ§è¡çªã«ç©ããã«æ±ãã®ã«äœ¿çšãããaminosalicylateã®è¬å€ã§éæãããäžåºŠå¯è§£ãç¶æããŸãã Mesalazineã¯æççå€ã§ããµã«ãã©ãŒé žå¡©ããã³éã¹ããã€ãã®æççè¬ãšæ§é çã«é¢é£ããŠããŸãã¢ã»ãã«ãµãªãã«é žã®ãããªãæœ°çæ§å€§è žçŸæ£ãã¯ããŒã³ç ãªã©ã®ççæ§è žçŸæ£ã®æ²»çã«äœ¿çšãããŸãã æœ°çæ§é¢ç¯ç å€§è žã©ã€ãã³ã°(ã³ãã³)ã®ççãåŒãèµ·ããæ ¢æ§ççè žçŸæ£ã®äžçš®ã§ãã å€§è žã®ã©ã€ãã³ã°ã«æœ°çãçæããè¿ããã³ç²æ¶²ã®åºè¡ããã³æåºãåŒãèµ·ããå¯èœæ§ããããŸãã Mesalazineã¯ãè žå ã®çç(èµ€ã¿ãè «ã)ãæå¶ããèã®çã¿ãåºè¡ãªã©ã®çç¶... ãã£ãšèŠã
ãã©ãã°ããªããªãŒãšã¯ãè¬ç©ã®è§£æŸãšåžåã®ããã®ç®çã®èº«äœéšäœã«è¬ãæç€ºããããã«å©çšãããæè¡ãæããŸãã éŒ»è¬æäžã¯ãéèå æäžã«å¶éãããè¬ã®ç³»çµ±çãªå¯çšæ§ã®ããã®ä»£æ¿ã«ãŒããšããŠäœ¿çšãããŠããŸããã ããã¯ã¢ã¬ã«ã®ãŒæ§ããã³éã¢ã¬ã«ã®ãŒæ§éŒ»çã®åŠçœ®ã®ããã®ç®¡çã®æã奜ãŸããã«ãŒããçé çãèŠçããã³éŒ»ã®æ··éã®åŠçœ®ã¯éŒ»çãå ±éã®é¢šéªããŸãã¯å¯éŒ»çã«é¢é£ä»ããããŸãã 錻ã®ã«ãŒãã¯ãè¿ éãã€é«ç³»çµ±çãªå¯çšæ§ã錻è ããè³ã«çŽæ¥è¬ãã¿ãŒã²ãã£ã³ã°ããå¯èœæ§ãèã«ããæåã®ãã¹ä»£è¬ã®åé¿ãå«ãé©ãã¹ãå©ç¹ã瀺ããŠããŸãã Intranasalã®è¬å€é é(ã錻ã®è¬å€é é)ã¯æ²»ç广(ããŒã«ã«ãå šèº«... ãã£ãšèŠã
ã€ã³ããã·ã¢ã®äººã ãç¹ã«äžå¹Žäžä»£ã«ãããå¥åº·ç®¡çæèã®é«ãŸãã¯ãäºæž¬æéäžã®ã€ã³ããã·ã¢æ é€è£å©é£ååžå Žã®æé·ã«å¥œåœ±é¿ãäžãããšäºæ³ããããã€ã³ããã·ã¢ã®äººå£ã®50ïŒ ã¯30æ³æªæºã§ããããã®ãããªå·šå€§ãªè¥å¹Žäººå£ã¯ãå€å¿ãªã©ã€ãã¹ã¿ã€ã«ã«ããé£ç掻ã®å€åã«æ¯ãããããã¿ãã³ãµããªã¡ã³ãã®éèŠãæŒãäžãããšäºæž¬ãããŠãããã€ã³ããã·ã¢ã®æ é€è£å©é£ååžå Žã¯ãäºæž¬æéäžïŒ2021ïœ2028幎ïŒã«å¹Žå¹³åæé·ç7.7ïŒ ã瀺ãã2028幎æ«ãŸã§ã«å£²äžé«ã§31å7,751äžç±³ãã«ãçªç Žãããšäºæž¬ãããã æšé²èŠå å¥åº·ãšãŠã§ã«ããŒã€ã³ã°ã«é¢ããæèã®é«ãŸããšãã€ã³ããã·ã¢å šåã«ããããããã幎霢局ã§ã®å¥åº·... ãã£ãšèŠã
äžå€®è²ŽæãããŒãã£(CPP)ã¯ãgonadotropinã«äŸåããªãææ¥æãšåŒã°ããŸãã äºæ¬¡æ§çç¹åŸŽã®éçºãå éæé·ãããã³ææ¥æã®æ£åžžãªå¹Žéœ¢ã®åã«éªšã®æçã«ããææ¥æå€åã®çºçã«ãã£ãŠç¹åŸŽä»ããããå åæ³é¢é£ã®çºéçŸæ£ã§ã(8人ã®å°å¥³ãš9人ã®ç·ã®å)ããã®æ¡ä»¶ã¯ãidiopathicã§ãã ããããäžå€®ã®äºæããªãææ¥æã®æãäžè¬çãªéºäŒçåå ã¯ãMKRN3éºäŒåã«ãããå€ç°ã§ããã éºäŒåŠã«å ããŠãæ¡ä»¶ã«åœ±é¿ãåãŒãå¯èœæ§ã®ãããã®ä»ã®åœ±é¿èŠå ã«ã¯ãæ é€ã瀟äŒçµæžç¶æ ãããã³ç°å¢å ã®ç¹å®ã®ååŠç©è³ªãžã®æŽé²ãå«ãŸããŸããã°ããŒãã«ã»ã»ã³ãã©ã«ã»ãã¬ã³ãŒã¹ãã»ãããŒãã£ã»ããŒã±ãã - ã³ã... ãã£ãšèŠã
äžççãªæååºå€åžå Žã¯ã§è©äŸ¡ãããŸããUS$30,773.2 Mn2021幎ã¯äŸ¡å€ã®äŸ¡å€ã«éããèŠéãã§ãUS$ 57,337.5 ã¡ãŒãã«ã«ãã£ãŠ2028幎ãåãåãã9.4%ã®CAGRéã®è·é¢2022幎ã2028幎ãåãåãã æååºå€åžå Žã¯ãæ ¢æ§çŸæ£ã®å¢æ®ã«ãã匷çãªæé·ãçµéšããäžçäžã®æååºå€ã«å¯ŸããéèŠãé«ãŸããŸãã ãŸããäžçäžã«ãããæ°èŠæååºå€ã®éçºã«æ³šåããã²ãªã¢ããªã®äººå£å¢å ãæåŸ ãããŠããŸãã ããããªãããæååºè¬ãå³ããæ¿åºèŠå¶ã«é¢é£ããå¯äœçšãªã©ã®èŠå ã¯ãäžççãªæååºè¬åžå Žã®æé·ã劚ããããšãæåŸ ãããŸããã°ããŒãã«ã¢ã³ãååºå€åžå Ž: å°åã€ã³ãµã€ããžãªã°ã©ãã£... ãã£ãšèŠã